News & Events about Insmed Incorporated.
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire BRIDGEWATER, N.J., Feb. 3, 2023 BRIDGEWATER, N.J., Feb. 3, 2023 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical...
Emerald Advisers, LLC celebrated 30 years of managing client funds in 2022, and its portfolio managers and research analysts help kick off 2023 by presenting their insights and outlook for the new year at the 30th Annual Groundhog Day Investment Forum on February 2nd in King of Prussia, PA...
Insmed (NASDAQ:INSM Get Rating) had its price target cut by Barclays from $37.00 to $35.00 in a research report report published on Friday, Benzinga reports. They currently have an overweight rating on the biopharmaceutical companys stock. Other equities research analysts also ...
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire BRIDGEWATER, N.J., Jan. 20, 2023 BRIDGEWATER, N.J., Jan. 20, 2023 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical...
Insmed Provides Business Updates and Near-Term Strategic Outlook at 41st Annual J.P. Morgan Healthcare Conference Insmed Provides Business Updates and Near-Term Strategic Outlook at 41st Annual J.P. Morgan Healthcare Conference PR Newswire BRIDGEWATER, N.J., Jan. 6, 2023 Topline Data from Phase 2...